Neuronetics Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Neuronetics
STIM Stock  USD 0.84  0.04  5.00%   
Neuronetics financial statements provide useful quarterly and yearly information to potential Neuronetics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Neuronetics financial statements helps investors assess Neuronetics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Neuronetics' valuation are summarized below:
Gross Profit
49.7 M
Profit Margin
(0.45)
Market Capitalization
25.4 M
Enterprise Value Revenue
0.7098
Revenue
72.1 M
There are over one hundred nineteen available fundamental ratios for Neuronetics, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check Neuronetics' last-minute fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road.

Neuronetics Total Revenue

59.29 Million

Check Neuronetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuronetics' main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.4 M or Interest Expense of 4.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.0 or PTB Ratio of 1.94. Neuronetics financial statements analysis is a perfect complement when working with Neuronetics Valuation or Volatility modules.
  
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Neuronetics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets100.9 M115.8 M65.5 M
Slightly volatile
Short and Long Term Debt Total44.7 M62.5 M32.9 M
Slightly volatile
Other Current Liabilities9.3 M10.9 M7.5 M
Slightly volatile
Total Current Liabilities20.5 M19.8 M16.6 M
Slightly volatile
Other Liabilities1.2 M746.1 K916.3 K
Slightly volatile
Property Plant And Equipment Net3.9 M4.8 M2.8 M
Slightly volatile
Current Deferred Revenue2.2 M1.6 M1.7 M
Slightly volatile
Accounts Payable3.8 M4.8 M2.7 M
Slightly volatile
Cash68.7 M59.7 M44.7 M
Slightly volatile
Non Current Assets Total13.4 M22 M8.2 M
Slightly volatile
Non Currrent Assets Other7.4 M8.6 M4.2 M
Slightly volatile
Other Assets0.951.013.1 M
Pretty Stable
Long Term Debt34 M59.3 M25 M
Slightly volatile
Cash And Short Term Investments69.7 M60.6 M45.3 M
Slightly volatile
Net Receivables9.2 M17.8 M6.5 M
Slightly volatile
Common Stock Total Equity329.6 K313.9 K117.3 K
Slightly volatile
Common Stock Shares Outstanding17.5 M28.7 M9.7 M
Slightly volatile
Long Term Debt Total28.2 M26.3 M21.9 M
Slightly volatile
Liabilities And Stockholders Equity100.9 M115.8 M65.5 M
Slightly volatile
Non Current Liabilities Total63.4 M61.8 M121.9 M
Slightly volatile
Capital Surpluse238.9 M463.1 M162 M
Slightly volatile
Inventory5 M8.1 M3.5 M
Slightly volatile
Other Current Assets7.6 M7.3 M2.5 M
Slightly volatile
Other Stockholder Equity274.4 M410 M153.5 M
Slightly volatile
Total Liabilities78.2 M81.6 M138.2 M
Slightly volatile
Property Plant And Equipment Gross4.3 M7.6 M3 M
Slightly volatile
Short and Long Term Debt16.1 M15.1 M10.3 M
Slightly volatile
Preferred Stock Total Equity197.7 M215.2 M182.8 M
Slightly volatile
Total Current Assets87.4 M93.8 M57.4 M
Slightly volatile
Short Term Debt1.6 M1.7 M7 M
Very volatile
Common Stock190.6 K291 K105.9 K
Slightly volatile
Property Plant Equipment2.7 M2.3 M2.1 M
Slightly volatile
Net Working Capital75 M74 M48.5 M
Slightly volatile
Intangible Assets2.2 M4.2 M1.3 M
Slightly volatile
Deferred Long Term Liabilities905.7 K953.4 K2.2 M
Very volatile
Capital Stock253.4 K291 K203.4 K
Slightly volatile
Short Term Investments1.2 M905 K1.1 M
Slightly volatile
Capital Lease Obligations4 M3.2 M3.4 M
Slightly volatile
Long Term Investments1.1 M661 K1.6 M
Slightly volatile
Non Current Liabilities Other3.2 M3.4 M2.8 M
Slightly volatile

Neuronetics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.3 M4.2 M2.8 M
Slightly volatile
Depreciation And Amortization1.4 M2 M1.1 M
Slightly volatile
Interest Expense4.2 M5.4 M3 M
Slightly volatile
Selling General Administrative19.4 M25.4 M13.5 M
Slightly volatile
Selling And Marketing Expenses41.1 M47.3 M31.4 M
Slightly volatile
Total Revenue59.3 M71.3 M46.4 M
Slightly volatile
Gross Profit45.2 M51.7 M36 M
Slightly volatile
Other Operating Expenses84.8 M101.9 M64.2 M
Slightly volatile
Research Development10.2 M9.5 M8.9 M
Slightly volatile
Cost Of Revenue14.1 M19.6 M10.4 M
Slightly volatile
Total Operating Expenses70.7 M82.3 M53.8 M
Slightly volatile
Reconciled Depreciation1.3 M2 M910.6 K
Slightly volatile

Neuronetics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock254.8 K268.2 K7.8 M
Very volatile
Stock Based Compensation4.7 M7.3 M2.7 M
Slightly volatile
Begin Period Cash Flow63.4 M70.3 M43.4 M
Slightly volatile
Depreciation1.2 M2 M941.9 K
Slightly volatile
Other Non Cash Items3.1 M2.9 M994.6 K
Slightly volatile
Capital Expenditures1.6 M2.4 M998.9 K
Slightly volatile
Total Cash From Financing Activities23.6 M22.7 M19.3 M
Slightly volatile
End Period Cash Flow68.7 M59.7 M44.7 M
Slightly volatile
Change To Netincome10.6 M10.1 M3.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.491.16481.0975
Slightly volatile
Days Sales Outstanding95.8291.255150.104
Slightly volatile
Stock Based Compensation To Revenue0.05740.10260.0439
Slightly volatile
Capex To Depreciation0.951.1810.8924
Slightly volatile
EV To Sales1.131.2040.8698
Slightly volatile
Inventory Turnover3.782.42723.6484
Slightly volatile
Days Of Inventory On Hand101150111
Slightly volatile
Payables Turnover3.124.13364.0761
Slightly volatile
Sales General And Administrative To Revenue0.260.35640.2671
Slightly volatile
Research And Ddevelopement To Revenue0.20.13340.204
Slightly volatile
Capex To Revenue0.01970.03320.0182
Slightly volatile
Cash Per Share2.012.114884
Slightly volatile
Days Payables Outstanding10988.300293.0258
Slightly volatile
Income Quality0.721.06120.8306
Slightly volatile
Intangibles To Total Assets0.03810.03630.0161
Slightly volatile
Current Ratio3.624.73423.3451
Slightly volatile
Receivables Turnover3.83.99988.1257
Slightly volatile
Graham Number5.055.317610.4 K
Slightly volatile
Capex Per Share0.07850.082717.0434
Slightly volatile
Revenue Per Share2.372.48961.7 K
Slightly volatile
Interest Debt Per Share2.172.28741.1 K
Slightly volatile
Debt To Assets0.510.51910.6044
Slightly volatile
Operating Cycle143242158
Slightly volatile
Days Of Payables Outstanding10988.300293.0258
Slightly volatile
Ebt Per Ebit1.250.98811.1703
Slightly volatile
Quick Ratio3.424.32573.1489
Slightly volatile
Net Income Per E B T1.251.211.1761
Very volatile
Cash Ratio2.893.01222.6276
Slightly volatile
Days Of Inventory Outstanding101150111
Slightly volatile
Days Of Sales Outstanding95.8291.255150.104
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.851.07391.0356
Pretty Stable
Fixed Asset Turnover20.8714.920119.9175
Slightly volatile
Debt Ratio0.510.51910.6044
Slightly volatile
Price Sales Ratio1.491.16481.0975
Slightly volatile
Asset Turnover0.780.6160.9832
Slightly volatile
Gross Profit Margin0.850.72470.7879
Slightly volatile

Neuronetics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap249.4 K280.5 K305.5 K
Slightly volatile
Enterprise Value787.4 K828.8 K2 M
Slightly volatile

Neuronetics Fundamental Market Drivers

Cash And Short Term Investments60.6 M

Neuronetics Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Neuronetics Financial Statements

Neuronetics investors utilize fundamental indicators, such as revenue or net income, to predict how Neuronetics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.6 M2.2 M
Total Revenue71.3 M59.3 M
Cost Of Revenue19.6 M14.1 M
Stock Based Compensation To Revenue 0.10  0.06 
Sales General And Administrative To Revenue 0.36  0.26 
Research And Ddevelopement To Revenue 0.13  0.20 
Capex To Revenue 0.03  0.02 
Revenue Per Share 2.49  2.37 
Ebit Per Revenue(0.43)(0.45)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
How To Invest In Neuronetics
Details
Is Neuronetics Stock a good investment?
Details
What is Neuronetics' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.22)
Revenue Per Share
2.453
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.17)
Return On Equity
(1.00)
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY